VOYA Investment Management’s Palvella Therapeutics PVLA Stock Holding History

VOYA Investment Management’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$874K	Buy	5,716 +564	+11%	+$68.5K	﹤0.01%	1570
2026 Q1	$642K	Buy	+5,152	New	+$537K	﹤0.01%	1627
2021 Q2	–	Sell	-310	Closed	-$64K	–	2912
2021 Q1	$64K	Hold	310	–	–	﹤0.01%	2726
2020 Q4	$62K	Buy	310 +79	+34%	+$16.4K	﹤0.01%	2636
2020 Q3	$38K	Hold	231	–	–	﹤0.01%	2463
2020 Q2	$57K	Sell	231 -95	-29%	-$22.2K	﹤0.01%	2438
2020 Q1	$59K	Hold	326	–	–	﹤0.01%	2466
2019 Q4	$94K	Buy	326 +49	+18%	+$13.6K	﹤0.01%	2563
2019 Q3	$76K	Hold	277	–	–	﹤0.01%	2454
2019 Q2	$104K	Hold	277	–	–	﹤0.01%	2463
2019 Q1	$74K	Hold	277	–	–	﹤0.01%	2477
2018 Q4	$59K	Hold	277	–	–	﹤0.01%	2471
2018 Q3	$124K	Hold	277	–	–	﹤0.01%	2463
2018 Q2	$112K	Buy	277 +31	+13%	+$14.8K	﹤0.01%	2500
2018 Q1	$134K	Hold	246	–	–	﹤0.01%	2424
2017 Q4	$149K	Hold	246	–	–	﹤0.01%	2429
2017 Q3	$113K	Hold	246	–	–	﹤0.01%	2523
2017 Q2	$100K	Buy	+246	New	+$71.9K	﹤0.01%	2575

Other funds holding PVLA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

VOYA Investment Management's PVLA Position: Q2 2026 in Review

VOYA Investment Management increased its Palvella Therapeutics (PVLA) stake by 11% in Q2 2026, buying an estimated $68.5K and bringing the position to 5,716 shares worth $874K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

VOYA Investment Management first reported a position in PVLA in Q2 2017 and has held it in 18 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

VOYA Investment Management held 5,716 shares of Palvella Therapeutics worth $874K as of Q2 2026.
VOYA Investment Management bought 564 Palvella Therapeutics shares in Q2 2026, an estimated $68.5K.
Palvella Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1570 holding.
VOYA Investment Management first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 18 quarters since.
197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.